At a glance
ClinicalIndex Comparison RecordN/ACompleted· 727 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
LUX-Dx Insertable Cardiac Monitor Remote Programming and Performance Study
In Brief
An observational study for Atrial Fibrillation and 2 related conditions. Completed, enrolled 727 participants across 24 sites.
Detailed Summary
The LUX-Dx PERFORM Study had two primary objects which were (1) to characterize, in a general patient population, the utilization of the remote programming feature of the Boston Scientific (BSC) Insertable Cardiac Monitor (ICM) device and (2) to collect data to characterize the performance of arrhythmia detection algorithms. Data was also collected to characterize the ICM system related safety events.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation, Syncope, Cryptogenic Stroke
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedFeb 2021
Enrollment StartMar 2021
Primary CompletionMay 2023
TodayJul 2026
First PostedFeb 1, 2021
Enrollment StartMar 5, 2021
Primary CompletionMay 18, 2023
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 5.4 years ago